SHC
Get informed when a big investor buys or sells
+ FollowOvervalued by 135.5% based on the discounted cash flow analysis.
| Market cap | $4.46 Billion |
|---|---|
| Enterprise Value | $6.41 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.27 |
| Beta | 1.82 |
| Outstanding Shares | 284,887,000 |
| P/E Ratio | 37.82 |
|---|---|
| PEG | -12.59 |
| Price to Sales | 3.82 |
| Price to Book Ratio | 7.64 |
| Enterprise Value to Revenue | 5.39 |
| Enterprise Value to EBIT | 19.76 |
| Enterprise Value to Net Income | 54 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 3.65 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 150.40% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 97.03%▲ 3.82% |
|---|---|
| Total Invested | $3.93B▼ 15.94% |
| Investors Holding | 293▲ 7.00% |
No data
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses - Sterigen...